- Home
- WGRX vs KRRO Comparison
WGRX vs KRRO Comparison
Compare WGRX & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WGRX | KRRO |
|---|---|---|
| Founded | 2022 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.2M | 58.6M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WGRX | KRRO |
|---|---|---|
| Price | $0.57 | $8.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $74.17 |
| AVG Volume (30 Days) | ★ 997.7K | 615.6K |
| Earning Date | 11-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,077,635.00 | $7,371,000.00 |
| Revenue This Year | N/A | $144.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 495.93 | N/A |
| 52 Week Low | $0.34 | $5.20 |
| 52 Week High | $7.04 | $55.89 |
Technical Indicators
Market Signals| Indicator | WGRX | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 32.84 |
| Support Level | $0.52 | $5.20 |
| Resistance Level | $0.64 | $7.97 |
| Average True Range (ATR) | 0.05 | 0.59 |
| MACD | 0.01 | 1.39 |
| Stochastic Oscillator | 45.62 | 83.45 |
Price Performance
Historical ComparisonAbout WGRX Wellgistics Health Inc.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.